European Healthtech startup funding raised during January 2023.
In January 2023, 66 European Healthtech companies raised a combined €538M across 66 funding rounds, down 44.6% versus January 2022. UK led by capital raised, and Andera Partners was the most active investor. Data as of 9 Jul 2026.
10 exits · €140M disclosed.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Amolyt Pharma | Series C | Jan 2023 | €129M |
| SoniVie | Series C | Jan 2023 | €56M |
| Grey Wolf Therapeutics | Series B | Jan 2023 | €45M |
| Peppy | Series B |
| Verogen | Acquisition | Jan 2023 | €140M |
| Jan 2023 |
| €42M |
| Evosep | Other | Jan 2023 | €37M |
| Perspectum | Series C | Jan 2023 | €34M |
| ExeVir Bio | Debt | Jan 2023 | €25M |
| Ethris | Other | Jan 2023 | €15M |
| HVR Cardio | Series B | Jan 2023 | €11M |
| Inflow | Series A | Jan 2023 | €10M |
| Tetra Pharm Technologies | Series A | Jan 2023 | €9.0M |
| BioVersys | Other | Jan 2023 | €8.5M |
| PneumoWave | Series A | Jan 2023 | €8.5M |
| LinkinVax | Other | Jan 2023 | €7.3M |
| NeoPhore | Series B | Jan 2023 | €6.8M |